Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

A. Bronden; H. H. Nerild; C. C. Nexoe-Larsen; P. H. Hellmann; M. Baekdal; I. M. Gether; M. P. Gillum; Bolette Hartmann; L. B. Knudsen; L. V. Jacobsen; J. F. Rehfeld; J. J. Holst; T. Vilsboll; D. P. Sonne; F. K. Knop

Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

A. Bronden, H. H. Nerild, C. C. Nexoe-Larsen, P. H. Hellmann, M. Baekdal, I. M. Gether, M. P. Gillum, Bolette Hartmann, L. B. Knudsen, L. V. Jacobsen, J. F. Rehfeld, J. J. Holst, T. Vilsboll, D. P. Sonne, F. K. Knop

Original language	English
Publication date	Sep 2021
Number of pages	1
Publication status	Published - Sep 2021

Cite this

Bronden, A., Nerild, H. H., Nexoe-Larsen, C. C., Hellmann, P. H., Baekdal, M., Gether, I. M., Gillum, M. P., Hartmann, B., Knudsen, L. B., Jacobsen, L. V., Rehfeld, J. F., Holst, J. J., Vilsboll, T., Sonne, D. P., & Knop, F. K. (2021). Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity. 94-94.

Bronden, A , Nerild, HH, Nexoe-Larsen, CC, Hellmann, PH , Baekdal, M , Gether, IM, Gillum, MP, Hartmann, B, Knudsen, LB, Jacobsen, LV, Rehfeld, JF, Holst, JJ, Vilsboll, T , Sonne, DP & Knop, FK 2021, 'Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity', pp. 94-94.

@conference{3ccc52ed48ea480eb40cc59c34a3aeaf,

title = "Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity",

author = "A. Bronden and Nerild, {H. H.} and Nexoe-Larsen, {C. C.} and Hellmann, {P. H.} and M. Baekdal and Gether, {I. M.} and Gillum, {M. P.} and Bolette Hartmann and Knudsen, {L. B.} and Jacobsen, {L. V.} and Rehfeld, {J. F.} and Holst, {J. J.} and T. Vilsboll and Sonne, {D. P.} and Knop, {F. K.}",

year = "2021",

month = sep,

language = "English",

pages = "94--94",

}

TY - ABST

T1 - Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

AU - Bronden, A.

AU - Nerild, H. H.

AU - Nexoe-Larsen, C. C.

AU - Hellmann, P. H.

AU - Baekdal, M.

AU - Gether, I. M.

AU - Gillum, M. P.

AU - Hartmann, Bolette

AU - Knudsen, L. B.

AU - Jacobsen, L. V.

AU - Rehfeld, J. F.

AU - Holst, J. J.

AU - Vilsboll, T.

AU - Sonne, D. P.

AU - Knop, F. K.

PY - 2021/9

Y1 - 2021/9

M3 - Conference abstract for conference

SP - 94

EP - 94

ER -